Dr Neil E Fuehrer, MD | |
5440 South St Ste 200, Lincoln, NE 68506-2116 | |
(402) 465-1900 | |
(402) 465-1973 |
Full Name | Dr Neil E Fuehrer |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 18 Years |
Location | 5440 South St Ste 200, Lincoln, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487835757 | NPI | - | NPPES |
ENROLLED | Medicaid | MN |
Facility Name | Location | Facility Type |
---|---|---|
Bryan Medical Center | Lincoln, NE | Hospital |
Faith Regional Health Services | Norfolk, NE | Hospital |
Chi Health St. Elizabeth | Lincoln, NE | Hospital |
The Nebraska Medical Center | Omaha, NE | Hospital |
Columbus Community Hospital | Columbus, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Platte Nebraska Hospital Corporation | 6507856697 | 181 |
Pathology Medical Services Pc | 0648255265 | 10 |
News Archive
Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.
› Verified 5 days ago
Entity Name | North Platte Nebraska Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700855533 PECOS PAC ID: 6507856697 Enrollment ID: O20040512000889 |
News Archive
Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.
› Verified 5 days ago
Entity Name | Pathology Medical Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851455646 PECOS PAC ID: 0648255265 Enrollment ID: O20041022000417 |
News Archive
Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Neil E Fuehrer, MD 5440 South St Ste 200, Lincoln, NE 68506-2116 Ph: (402) 465-1900 | Dr Neil E Fuehrer, MD 5440 South St Ste 200, Lincoln, NE 68506-2116 Ph: (402) 465-1900 |
News Archive
Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.
› Verified 5 days ago
Dr. Aina Inese Silenieks, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Dr. Tyler Ryan Teichmeier, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 | |
Matthias I Okoye, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-486-3447 Fax: 402-486-3477 | |
Dr. Deborah Kay Davidson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Jon R Steinhauer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Dr. Charles Meehan Reese, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 |